Received May 7, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | C47XX | — |
received only the diluent of Hiberix; received only the diluent of Hiberix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 8-month-old male patient who received Hib (Hiberix) (batch number C47XX, expiry date 20-OCT-2026) for prophylaxis. On 26-MAR-2026, the patient received Hiberix. On 26-MAR-2026, an unknown time after receiving Hiberix, the patient experienced inappropriate dose of vaccine administered (Verbatim: received only the diluent of Hiberix) and inappropriate preparation of medication (Verbatim: received only the diluent of Hiberix). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 27-APR-2026 Reporter wanted to know how to proceed with two patients that received only the diluent of Hiberix. She was not aware of which two of nine patients received it, thus, the adverse event details of each of those nine was taken. This case is one of the nine linked cases, reported by the same reporter.; Sender's Comments: US-GSK-US2026057334:Same reporter/Different patient US-GSK-US2026057333:Same reporter/Different patient US-GSK-US2026057333:Same reporter/Different patient US-GSK-US2026057667:Same reporter/Different patient US-GSK-US2026057336:Same reporter/Different patient US-GSK-US2026057334:Same reporter/Different patient US-GSK-US2026057337:Same reporter/Different patient US-GSK-US2026057340:Same reporter/Different patient US-GSK-US2026057339:Same reporter/Different patient US-GSK-US2026057503:Same reporter/Different patient US-GSK-US2026057338:Same reporter/Different patient